News | TCTAP 2021 Virtual

TAVR & Antithrombotics Debates

April 22th Hot Debates 2021 in Interventional Cardiology of TCTAP 2021 Virtual

News | TCTAP 2021 Virtual

Ideal Revascularization for Left Main: Still No Definitive Winner or Loser

Two leading figures in unprotected left main coronary artery (ULMCA) disease engaged in a ¡°Hot Debate¡± over the merits of surgical versus percutaneous revascularization.in left main at TCTAP 2021 Virtual that kicked off online April 21.

News | TCTAP 2021 Virtual

The Long TAVR Journey: Chain of RCTs, Guideline Changes, and Future Directions

Martin Bert Leon, MD (Columbia University Medical Center/New York-Presbyterian Hospital, New York, USA) presented a special keynote lecture on the TAVR revolution and TAVR clinical evidence accumulated through decades during a plenary session at TCTAP 2021.

News | TCTAP 2021 Virtual

Plenary Session of TCTAP 2021: Special Keynote Lectures Part-I: Coronary and Antithrombotics

Updates on antithrombotic therapy for post-PCI ACS based on latest data

News | TCTAP 2021 Virtual

The Future of PCI: Indication, Technology, Outlook

Percutaneous coronary intervention (PCI) has gained incredible traction over the years - and leading cardiologists during a special keynote lecture at TCTAP 2021 Virtual on April 21 expounded in detail the direction of its promising future.

News | TCTAP 2021 Virtual

Atherosclerotic Plaque Progression and Imaging

The 11th winner of TCTAP award ¡°Master of the Masters¡±